Belite Bio
IPOPublic · United States · $275.0M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- belitebio.com
- Total Funding
- $275.0M
- Last Round
- $275.0M Private EquityJan 2025
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company advancing novel therapeutics targeting retinal degenerative eye diseases.
Summary
Belite Bio is a Biotech company based in United States. It has raised $275.0M in total across 1 round, most recently a $275.0M Private Equity round in Jan 2025. Investors include RA Capital Management, Eventide Asset Management and Marshall Wace.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company